MedCity News

MedCity News MedCity News: Healthcare innovation insights for professionals. We explain the latest trends in remote patient monitoring and clinical workflows.

MedCity News is a trusted source for healthcare innovation news and analysis for busy professionals and senior executives. As the healthcare industry undergoes an overall transformation with an intense focus on value-based care, MedCity News reports on how the healthcare ecosystem – payers, providers, healthtech startups, investors, medtech, diagnostics and biopharma companies — are striving towar

d that goal. We get beyond the press releases to tell you how health IT startups, artificial intelligence companies, life science companies and hospitals are reimagining care to improve outcomes and reduce costs in a variety of chronic diseases like heart failure and diabetes as well as in cancer. MedCity News produces events that bring together the healthcare ecosystem and important stakeholders to share insights on challenges and opportunities in the industry. Check out our upcoming events here: https://events.medcitynews.com/. For healthcare startups, we have created the MedCitizens community. As a member, you will be featured on MedCityNews.com and be able to reach our newsletter audience with regular updates about your company. For experienced industry professionals and senior executives eager to showcase their thought leadership or a strong opinion, we have created the MedCity Influencers program. This outside contributors’ program is published on MedCityNews.com and circulated through our daily newsletter. Our daily newsletter reaches a senior industry audience and captures the news highlights of the day. Our weekly biopharma newsletter, BioPulse, is a weekly wrap of the most notable news in the industry in the week. Our StartUPDATES newsletter is focused on sharing news and updates from our MedCitizens. Sign up for our newsletters here: https://medcitynews.com/subscribe/.

Eli Lilly Drug for 3 Obesity Targets Sets New High Bar for Weight Loss in a Clinical Trial
11/12/2025

Eli Lilly Drug for 3 Obesity Targets Sets New High Bar for Weight Loss in a Clinical Trial

The high dose of Eli Lilly’s retatrutide led to an average 28.7% loss in body weight measured at 68 weeks. These Phase 3 results are the first from the experimental obesity drug’s broad clinical trial program, which is on track to yield seven data readouts in the coming year.

How AI Is Reshaping Emergency Departments
11/12/2025

How AI Is Reshaping Emergency Departments

We are building a more connected system that bridges acute and post-acute settings by uniting insights across the continuum. The insights empower clinicians with the information they need at the moment they need it, resulting in faster, safer, and more human-centered care.

Improving Care Delivery With Ambient Technology
11/12/2025

Improving Care Delivery With Ambient Technology

A future where ambient technology is integrated across all hospital spaces — patient rooms, ORs, even waiting areas — will revolutionize decision-making to improve care.

Evvy Introduces At-Home UTI Test to Expedite Care
11/12/2025

Evvy Introduces At-Home UTI Test to Expedite Care

Evvy has launched an at-home UTI test that delivers results within one business day along with guidance from an Evvy clinician.

FDA Flexibility Leads to First Approved Gene Therapy for Rare Blood & Immune System Disorder
11/12/2025

FDA Flexibility Leads to First Approved Gene Therapy for Rare Blood & Immune System Disorder

Waskyra is the first FDA-approved gene therapy for the rare disease Wiskott-Aldrich syndrome and the first such approved product from a non-profit applicant, Fondazione Telethon. Data from Waskyra’s pivotal studies were presented this week during the annual meeting of the American Society of Hemat...

Biotech Showcase™: Where Innovation Meets Investment and Partnerships!Make Biotech Showcase your homebase during the bus...
10/12/2025

Biotech Showcase™: Where Innovation Meets Investment and Partnerships!

Make Biotech Showcase your homebase during the busiest week in healthcare.

The event convenes 3,200 life science leaders, including 1,200+ investors and over 340 presenting companies, for three days of breakthrough innovation, investment opportunities and strategic collaborations. Brought to you by EBD Group.

➡️ https://medcitynews.com/2025/12/biotech-showcase-where-innovation-meets-investment-and-partnerships/?utm_source=facebook&utm_medium=social&utm_campaign=sponsored&utm_term=2025-12-10&utm_content=ebdgroup

Make Biotech Showcase your homebase during the busiest week in healthcare. The event convenes 3,200 life science leaders, including 1,200+ investors and over 340 presenting companies, for three days of breakthrough innovation, investment opportunities and strategic collaborations.

10/12/2025

ŌURA is no longer just a sleep-focused wellness startup. It’s getting deeper into chronic disease management and healthcare integration, said its chief medical officer, Ricky Bloomfield.

We’re Running Out of Healthcare Workers. A Rose Gold Immigration Card Can Help.
10/12/2025

We’re Running Out of Healthcare Workers. A Rose Gold Immigration Card Can Help.

Americans suffer when hospitals close, nursing homes fall below care standards and mental health services become inaccessible. Immigration should be part of the solution.

President Trump Can Act Now To Make Healthcare Affordable
10/12/2025

President Trump Can Act Now To Make Healthcare Affordable

The Trump administration can immediately take these two price transparency administrative actions to reduce costs and improve affordability.

10/12/2025

A new unicorn: Function Health. Valued at $2.5 billion and helps people choose from a menu of 160+ biomarker tests to get a summary of their overall health. This is giving 23andMe vibes. What happens after the data and insights are received and if this drives "actual care being implemented"?

You can catch the entire conversation on our YT channel - link below.

Mark Cuban: Employers Are Unknowingly Profiting From Sick Workers’ Drug Costs
10/12/2025

Mark Cuban: Employers Are Unknowingly Profiting From Sick Workers’ Drug Costs

Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can violate fiduciary duties under ERISA. His company, Cost Plus Drugs, is partnering with organizations like Humana’s CenterWell to create direct-to-employer programs that byp...

Zocdoc Partners with Healthgrades to Help People Book Doctor’s Appointments
09/12/2025

Zocdoc Partners with Healthgrades to Help People Book Doctor’s Appointments

Through a partnership with Zocdoc, patients will be able to find providers who accept their insurance, view real-time availability for appointments and book appointments directly through the Healthgrades website.

Address


Alerts

Be the first to know and let us send you an email when MedCity News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to MedCity News:

  • Want your business to be the top-listed Media Company?

Share

About Us

• MedCity News is the leading web destination for the healthcare executive community covering the latest innovations in healthcare and venture capital investment.

• The company also hosts executive healthcare conferences nationwide, attended by executives from leading providers, life sciences companies, payers, startups and investors in healthcare

Read more at www.medcitynews.com